ByTrending Posts
Could Aiforia and Siemens Healthineers Transform Digital Pathology…
Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…
Can Ant Group’s AQ AI Health App Redefine…
Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…
Can GHX’s AI-Driven Supply Chain Solutions Transform How…
Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…
Is Stanford’s MedAgentBench Setting the New Gold Standard…
Key Highlights AI benchmarking moves beyond knowledge tests: Unlike earlier evaluations that focused on exams like the USMLE,…
Will Apple’s FDA-Cleared Hypertension Detection Feature on the…
Key Highlights FDA Approval Unlocks a New Era in Preventive CareApple’s hypertension detection feature, cleared by the U.S.…
Is Novartis Deepening Its Bet on AI-Enabled Molecular…
Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has broadened its partnership…
Will Levita’s MARS Platform Redefine Solo Surgery with…
Key Highlights: Autonomous Camera Enables Solo Laparoscopic Surgery At Clínica Las Condes in Santiago, Chile, a gallbladder removal…
Will the FDA’s Panel Shape the Future of…
Key Highlights: Advisory Meeting to Tackle Generative AI in Mental Health The FDA has formally scheduled a meeting…
Will Tempus AI’s FDA Clearance Redefine the Future…
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Trending Posts
Latest Stories
Could Roche’s Giredestrant Become the New Standard for Early-Stage ER-Positive Breast Cancer?
Basel, Switzerland – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the…
Could GSK’s Twice-Yearly Asthma Drug Change Long-Term Treatment for Patients?
United States GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA) has…
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology Testing
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has…
Amgen Takes Steps With U.S. Government to Reduce Prescription Drug Costs for American Patients
Thousand Oaks, California Amgen announced that it is working with the U.S. government on new…
Gallery
